These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 25867460

  • 1. Polyneuropathy with anti-sulfatide and anti-MAG antibodies: clinical, neurophysiological, pathological features and response to treatment.
    Campagnolo M, Ferrari S, Dalla Torre C, Cabrini I, Cacciavillani M, Lucchetta M, Ruggero S, Toffanin E, Cavallaro T, Briani C.
    J Neuroimmunol; 2015 Apr 15; 281():1-4. PubMed ID: 25867460
    [Abstract] [Full Text] [Related]

  • 2. [Rapid improvement by rituximab treatment in a case of demyelinating polyneuropathy with anti-myelin-associated glycoprotein antibody].
    Motoyama R, Yamakawa K, Suzuki S, Kusunoki S, Tanaka M.
    Rinsho Shinkeigaku; 2011 Oct 15; 51(10):761-4. PubMed ID: 22019868
    [Abstract] [Full Text] [Related]

  • 3. IgM monoclonal gammopathy-associated neuropathies with different IgM specificity.
    Matà S, Borsini W, Ambrosini S, Toscani L, Barilaro A, Piacentini S, Sorbi S, Lolli F.
    Eur J Neurol; 2011 Aug 15; 18(8):1067-73. PubMed ID: 21261794
    [Abstract] [Full Text] [Related]

  • 4. Neurophysiological and clinical responses to rituximab in patients with anti-MAG polyneuropathy.
    Zara G, Zambello R, Ermani M.
    Clin Neurophysiol; 2011 Dec 15; 122(12):2518-22. PubMed ID: 21680240
    [Abstract] [Full Text] [Related]

  • 5. Antibodies to myelin-associated glycoprotein (anti-Mag) in IgM amyloidosis may influence expression of neuropathy in rare patients.
    Garces-Sanchez M, Dyck PJ, Kyle RA, Zeldenrust S, Wu Y, Ladha SS, Klein CJ.
    Muscle Nerve; 2008 Apr 15; 37(4):490-5. PubMed ID: 18236455
    [Abstract] [Full Text] [Related]

  • 6. Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.
    Kuijf ML, Eurelings M, Tio-Gillen AP, van Doorn PA, van den Berg LH, Hooijkaas H, Stork J, Notermans NC, Jacobs BC.
    Neurology; 2009 Sep 01; 73(9):688-95. PubMed ID: 19720975
    [Abstract] [Full Text] [Related]

  • 7. Anti-sulfatide/galactocerebroside antibodies in immunoglobulin M paraproteinemic neuropathies.
    Boso F, Ruggero S, Giannotta C, Benedetti L, Marfia GA, Ermani M, Campagnolo M, Salvalaggio A, Gallia F, De Michelis C, Visentin A, Bianco M, Ruiz M, Mataluni G, Nobile-Orazio E, Briani C.
    Eur J Neurol; 2017 Nov 01; 24(11):1334-1340. PubMed ID: 28782863
    [Abstract] [Full Text] [Related]

  • 8. Anti-MAG IgM paraproteins from some patients with polyneuropathy associated with IgM paraproteinemia also react with sulfatide.
    Ilyas AA, Cook SD, Dalakas MC, Mithen FA.
    J Neuroimmunol; 1992 Mar 01; 37(1-2):85-92. PubMed ID: 1372333
    [Abstract] [Full Text] [Related]

  • 9. Anti-sulfatide IgM antibodies in peripheral neuropathy: to test or not to test?
    Giannotta C, Di Pietro D, Gallia F, Nobile-Orazio E.
    Eur J Neurol; 2015 May 01; 22(5):879-82. PubMed ID: 25597226
    [Abstract] [Full Text] [Related]

  • 10. Rituximab in the treatment of polyneuropathy associated with anti-MAG antibodies.
    Renaud S, Gregor M, Fuhr P, Lorenz D, Deuschl G, Gratwohl A, Steck AJ.
    Muscle Nerve; 2003 May 01; 27(5):611-5. PubMed ID: 12707982
    [Abstract] [Full Text] [Related]

  • 11. Can electrophysiology differentiate polyneuropathy with anti-MAG/SGPG antibodies from chronic inflammatory demyelinating polyneuropathy?
    Capasso M, Torrieri F, Di Muzio A, De Angelis MV, Lugaresi A, Uncini A.
    Clin Neurophysiol; 2002 Mar 01; 113(3):346-53. PubMed ID: 11897535
    [Abstract] [Full Text] [Related]

  • 12. Long-term disability and prognostic factors in polyneuropathy associated with anti-myelin-associated glycoprotein (MAG) antibodies.
    Galassi G, Tondelli M, Ariatti A, Benuzzi F, Nichelli P, Valzania F.
    Int J Neurosci; 2017 May 01; 127(5):439-447. PubMed ID: 27188752
    [Abstract] [Full Text] [Related]

  • 13. Remission of demyelinating polyneuropathy with immunoadsorption, low dose corticosteroids and anti-CD20 monoclonal antibody.
    Rech J, Hueber AJ, Kallert S, Leipe J, Kalden JR, Beck M, Schett G, Schulze-Koops H.
    Ther Apher Dial; 2008 Jun 01; 12(3):205-8. PubMed ID: 18503697
    [Abstract] [Full Text] [Related]

  • 14. Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies.
    Magy L, Kaboré R, Mathis S, Lebeau P, Ghorab K, Caudie C, Vallat JM.
    J Immunol Res; 2015 Jun 01; 2015():450391. PubMed ID: 26065001
    [Abstract] [Full Text] [Related]

  • 15. Antibody-associated polyneuropathy syndromes: principles and treatment.
    Kornberg AJ, Pestronk A.
    Semin Neurol; 2003 Jun 01; 23(2):181-90. PubMed ID: 12894383
    [Abstract] [Full Text] [Related]

  • 16. Outcomes after single-cycle rituximab monotherapy in patients with anti-MAG polyneuropathy: A bi-center experience with an average follow-up of 11 years.
    Benedetti L, Garnero M, Demichelis C, Grandis M, Briani C, Beltramini S, Bellucci M, Prada V, Massa F, Gastaldi M, Schenone A, Franciotta D.
    J Neuroimmunol; 2019 Dec 15; 337():577081. PubMed ID: 31677562
    [Abstract] [Full Text] [Related]

  • 17. Severe cranial nerve involvement in a patient with monoclonal anti-MAG/SGPG IgM antibody and localized hard palate amyloidosis.
    Yoshida T, Yazaki M, Gono T, Tazawa K, Morita H, Matsuda M, Funakoshi K, Yuki N, Ikeda S.
    J Neurol Sci; 2006 May 15; 244(1-2):167-71. PubMed ID: 16546215
    [Abstract] [Full Text] [Related]

  • 18. Predictors of response to rituximab in patients with neuropathy and anti-myelin associated glycoprotein immunoglobulin M.
    Benedetti L, Briani C, Grandis M, Vigo T, Gobbi M, Ghiglione E, Carpo M, Cocito D, Caporale CM, Sormani MP, Mancardi GL, Nobile-Orazio E, Schenone A.
    J Peripher Nerv Syst; 2007 Jun 15; 12(2):102-7. PubMed ID: 17565535
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic options and management of polyneuropathy associated with anti-MAG antibodies.
    Vallat JM, Magy L, Ciron J, Corcia P, Le Masson G, Mathis S.
    Expert Rev Neurother; 2016 Sep 15; 16(9):1111-9. PubMed ID: 27267749
    [Abstract] [Full Text] [Related]

  • 20. [Monoclonal IgM autoantibody activity vis-à-vis glycoconjugates of peripheral nerves: apropos of 112 cases].
    Caudie C, Vial C, Petiot P, Bancel J, Lombard C, Gonnaud PM.
    Ann Biol Clin (Paris); 2001 Sep 15; 59(5):567-77. PubMed ID: 11602387
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.